Keyphrases
Alternative Splicing
100%
Drug Resistance
100%
Tumor Drugs
100%
PIK3CD
100%
Tumor Aggressiveness
100%
African American Prostate Cancer
100%
Prostate Cancer
66%
African American
66%
RNA Splicing
66%
European American
66%
Molecular Targets
33%
Novel Biomarkers
33%
Poor Survival
33%
Splice Variant
33%
Proliferative Activity
33%
Cancer Therapeutics
33%
Invasive Ability
33%
PI3K Inhibitor
33%
Prostate Cancer Cell Lines
33%
Potential Molecular Mechanism
33%
Oncogenic Potential
33%
African American Men
33%
Aggressive Prostate Cancer
33%
Tuberous Sclerosis Complex
33%
Chemotherapy Resistance
33%
Splicing Event
33%
Akt-mTOR Signaling
33%
Ectopic Overexpression
33%
Prostate Cancer Aggressiveness
33%
Mouse Xenograft Model
33%
Fibroblast Growth Factor Receptor 3 (FGFR3)
33%
CAL-101
33%
RASGRP2
33%
Critical Drivers
33%
RNA Splice Sites
33%
Prostate Cancer Disparities
33%
Idelalisib
33%
Developmental Therapeutics
33%
Biochemistry, Genetics and Molecular Biology
Alternative Splicing
100%
RNA Splicing
100%
Drug Resistance
100%
Cancer Cell
50%
Carcinogenesis
50%
RNA
50%
Protein Kinase B
50%
mTOR Signaling
50%
TSC2
50%
Fibroblast Growth Factor Receptor 3
50%
Medicine and Dentistry
Prostate Cancer
100%
Drug Resistance
100%
Alternative RNA Splicing
100%
Tumor
100%
RNA Splicing
33%
In Vitro
16%
Carcinogenesis
16%
Xenograft
16%
Biological Marker
16%
Protein Kinase B
16%
mTOR Signaling
16%
Prostate Cancer Cell Line
16%
Fibroblast Growth Factor Receptor 3
16%
Idelalisib
16%